Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Rotavirus Infections Drug market report explains the definition, types, applications, major countries, and major players of the Rotavirus Infections Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Bharat Biotech International Ltd
Medicago Inc
Nanotherapeutics Inc
Biological E Ltd
Curevac AG
UMN Pharma Inc
Serum Institute of India Ltd
Beijing Minhai Biotechnology Co Ltd
Wuhan Institute of Biological Products Co Ltd
By Type:
RV-3BB
RV-625
UMN-2001
Rotavac-5C
Others
By End-User:
Clinic
Hospital
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Rotavirus Infections Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Rotavirus Infections Drug Outlook to 2028- Original Forecasts
-
2.2 Rotavirus Infections Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Rotavirus Infections Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Rotavirus Infections Drug Market- Recent Developments
-
6.1 Rotavirus Infections Drug Market News and Developments
-
6.2 Rotavirus Infections Drug Market Deals Landscape
7 Rotavirus Infections Drug Raw Materials and Cost Structure Analysis
-
7.1 Rotavirus Infections Drug Key Raw Materials
-
7.2 Rotavirus Infections Drug Price Trend of Key Raw Materials
-
7.3 Rotavirus Infections Drug Key Suppliers of Raw Materials
-
7.4 Rotavirus Infections Drug Market Concentration Rate of Raw Materials
-
7.5 Rotavirus Infections Drug Cost Structure Analysis
-
7.5.1 Rotavirus Infections Drug Raw Materials Analysis
-
7.5.2 Rotavirus Infections Drug Labor Cost Analysis
-
7.5.3 Rotavirus Infections Drug Manufacturing Expenses Analysis
8 Global Rotavirus Infections Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Rotavirus Infections Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Rotavirus Infections Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Rotavirus Infections Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Rotavirus Infections Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global RV-3BB Consumption and Growth Rate (2017-2022)
-
9.1.2 Global RV-625 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global UMN-2001 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Rotavac-5C Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Rotavirus Infections Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Rotavirus Infections Drug Market Analysis and Outlook till 2022
-
10.1 Global Rotavirus Infections Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Rotavirus Infections Drug Consumption (2017-2022)
-
10.2.2 Canada Rotavirus Infections Drug Consumption (2017-2022)
-
10.2.3 Mexico Rotavirus Infections Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.2 UK Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.3 Spain Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.4 Belgium Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.5 France Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.6 Italy Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.7 Denmark Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.8 Finland Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.9 Norway Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.10 Sweden Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.11 Poland Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.12 Russia Rotavirus Infections Drug Consumption (2017-2022)
-
10.3.13 Turkey Rotavirus Infections Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.2 Japan Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.3 India Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.4 South Korea Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.5 Pakistan Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.7 Indonesia Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.8 Thailand Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.9 Singapore Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.10 Malaysia Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.11 Philippines Rotavirus Infections Drug Consumption (2017-2022)
-
10.4.12 Vietnam Rotavirus Infections Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.2 Colombia Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.3 Chile Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.4 Argentina Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.5 Venezuela Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.6 Peru Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Rotavirus Infections Drug Consumption (2017-2022)
-
10.5.8 Ecuador Rotavirus Infections Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Rotavirus Infections Drug Consumption (2017-2022)
-
10.6.2 Kuwait Rotavirus Infections Drug Consumption (2017-2022)
-
10.6.3 Oman Rotavirus Infections Drug Consumption (2017-2022)
-
10.6.4 Qatar Rotavirus Infections Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Rotavirus Infections Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Rotavirus Infections Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Rotavirus Infections Drug Consumption (2017-2022)
-
10.7.2 South Africa Rotavirus Infections Drug Consumption (2017-2022)
-
10.7.3 Egypt Rotavirus Infections Drug Consumption (2017-2022)
-
10.7.4 Algeria Rotavirus Infections Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Rotavirus Infections Drug Consumption (2017-2022)
-
10.8.2 New Zealand Rotavirus Infections Drug Consumption (2017-2022)
11 Global Rotavirus Infections Drug Competitive Analysis
-
11.1 Bharat Biotech International Ltd
-
11.1.1 Bharat Biotech International Ltd Company Details
-
11.1.2 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Bharat Biotech International Ltd Rotavirus Infections Drug Main Business and Markets Served
-
11.1.4 Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Medicago Inc
-
11.2.1 Medicago Inc Company Details
-
11.2.2 Medicago Inc Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Medicago Inc Rotavirus Infections Drug Main Business and Markets Served
-
11.2.4 Medicago Inc Rotavirus Infections Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Nanotherapeutics Inc
-
11.3.1 Nanotherapeutics Inc Company Details
-
11.3.2 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Nanotherapeutics Inc Rotavirus Infections Drug Main Business and Markets Served
-
11.3.4 Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Biological E Ltd
-
11.4.1 Biological E Ltd Company Details
-
11.4.2 Biological E Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Biological E Ltd Rotavirus Infections Drug Main Business and Markets Served
-
11.4.4 Biological E Ltd Rotavirus Infections Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Curevac AG
-
11.5.1 Curevac AG Company Details
-
11.5.2 Curevac AG Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Curevac AG Rotavirus Infections Drug Main Business and Markets Served
-
11.5.4 Curevac AG Rotavirus Infections Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 UMN Pharma Inc
-
11.6.1 UMN Pharma Inc Company Details
-
11.6.2 UMN Pharma Inc Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 UMN Pharma Inc Rotavirus Infections Drug Main Business and Markets Served
-
11.6.4 UMN Pharma Inc Rotavirus Infections Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Serum Institute of India Ltd
-
11.7.1 Serum Institute of India Ltd Company Details
-
11.7.2 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Main Business and Markets Served
-
11.7.4 Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Beijing Minhai Biotechnology Co Ltd
-
11.8.1 Beijing Minhai Biotechnology Co Ltd Company Details
-
11.8.2 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Main Business and Markets Served
-
11.8.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Wuhan Institute of Biological Products Co Ltd
-
11.9.1 Wuhan Institute of Biological Products Co Ltd Company Details
-
11.9.2 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Main Business and Markets Served
-
11.9.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Rotavirus Infections Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Rotavirus Infections Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global RV-3BB Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global RV-625 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global UMN-2001 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Rotavac-5C Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Rotavirus Infections Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Rotavirus Infections Drug Market Analysis and Outlook to 2028
-
13.1 Global Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.5 France Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.3 India Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Rotavirus Infections Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Rotavirus Infections Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Rotavirus Infections Drug
-
Figure of Rotavirus Infections Drug Picture
-
Table Global Rotavirus Infections Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Rotavirus Infections Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global RV-3BB Consumption and Growth Rate (2017-2022)
-
Figure Global RV-625 Consumption and Growth Rate (2017-2022)
-
Figure Global UMN-2001 Consumption and Growth Rate (2017-2022)
-
Figure Global Rotavac-5C Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Table North America Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure United States Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure Germany Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure France Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure China Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure India Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table South America Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure Brazil Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure Bahrain Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure Nigeria Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Rotavirus Infections Drug Consumption by Country (2017-2022)
-
Figure Australia Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Rotavirus Infections Drug Consumption and Growth Rate (2017-2022)
-
Table Bharat Biotech International Ltd Company Details
-
Table Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bharat Biotech International Ltd Rotavirus Infections Drug Main Business and Markets Served
-
Table Bharat Biotech International Ltd Rotavirus Infections Drug Product Portfolio
-
Table Medicago Inc Company Details
-
Table Medicago Inc Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medicago Inc Rotavirus Infections Drug Main Business and Markets Served
-
Table Medicago Inc Rotavirus Infections Drug Product Portfolio
-
Table Nanotherapeutics Inc Company Details
-
Table Nanotherapeutics Inc Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanotherapeutics Inc Rotavirus Infections Drug Main Business and Markets Served
-
Table Nanotherapeutics Inc Rotavirus Infections Drug Product Portfolio
-
Table Biological E Ltd Company Details
-
Table Biological E Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biological E Ltd Rotavirus Infections Drug Main Business and Markets Served
-
Table Biological E Ltd Rotavirus Infections Drug Product Portfolio
-
Table Curevac AG Company Details
-
Table Curevac AG Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curevac AG Rotavirus Infections Drug Main Business and Markets Served
-
Table Curevac AG Rotavirus Infections Drug Product Portfolio
-
Table UMN Pharma Inc Company Details
-
Table UMN Pharma Inc Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table UMN Pharma Inc Rotavirus Infections Drug Main Business and Markets Served
-
Table UMN Pharma Inc Rotavirus Infections Drug Product Portfolio
-
Table Serum Institute of India Ltd Company Details
-
Table Serum Institute of India Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Ltd Rotavirus Infections Drug Main Business and Markets Served
-
Table Serum Institute of India Ltd Rotavirus Infections Drug Product Portfolio
-
Table Beijing Minhai Biotechnology Co Ltd Company Details
-
Table Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Main Business and Markets Served
-
Table Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Product Portfolio
-
Table Wuhan Institute of Biological Products Co Ltd Company Details
-
Table Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Main Business and Markets Served
-
Table Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Product Portfolio
-
Figure Global RV-3BB Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global RV-625 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global UMN-2001 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rotavac-5C Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Table North America Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure China Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Rotavirus Infections Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Rotavirus Infections Drug Consumption Forecast and Growth Rate (2022-2028)
-
